Plunkett Research Online: Cassava Sciences Inc

CASSAVA SCIENCES INC (SAVA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnosti.....



Cassava Sciences Inc
Ticker: SAVA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 512 501-2444
Fax: 650 624-8222
Address: 7801 N. Capital of Texas Highway
Suite 260
Austin, TX 78731 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs, Opioids
Neurodegenerative Diseases
Drug Development
Clinical-Stage Biotechnology
Clinical Testing
Contacts Description
Remi Barbier CEO/Chairman of the Board/Director/Founder/President
Eric Schoen CFO/Chief Accounting Officer
See More
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnosti.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2021 2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Simufilam
SavaDx
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: